Communiqués

21/05/20 Correvio Pharma : Obtains Final Order for Plan of Arrangement PR
15/05/20 Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders PR
06/05/20 Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA PR
04/05/20 Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19 PR
01/05/20 Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA PR
08/04/20 Correvio Pharma : Obtains Interim Order For Plan Of Arrangement PR
30/03/20 Correvio Pharma : Reports Full Year 2019 Financial Results PR
21/03/20 CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV BU
16/03/20 Correvio Pharma : ADVANZ PHARMA to Acquire Correvio PR
28/01/20 Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities PR
24/12/19 Correvio Pharma : TOP RANKED ROSEN LAW FIRM Reminds Correvio Pharma Corp. Investors of Important Deadline in Securities Action– CORV BU
24/12/19 Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events PR
13/12/19 CORREVIO PHARMA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Correvio Pharma Corp. and Encourages Investors to Contact the Firm BU
12/12/19 ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Correvio Pharma Corp. – CORV BU
11/12/19 Correvio Pharma : IIROC Trade Resumption - CORV AQ
10/12/19 Correvio Pharma : IIROC Trading Halt - CORV AQ
27/09/19 Correvio Pharma : to Present at the 2019 Cantor Global Healthcare Conference PR
04/09/19 Correvio Pharma : to Present at the H.C. Wainwright 21st Annual Global Investment Conference PR
07/08/19 Correvio Pharma : Closes Public Offering of 9,200,000 Common Shares PR
02/08/19 Correvio Pharma : Announces Pricing Of Public Offering Of Common Shares PR
01/08/19 Correvio Pharma : Announces Overnight Marketed Offering of Common Shares PR
01/05/19 Correvio Pharma : to Report First Quarter 2019 Financial Results on May 8, 2019 PR
02/04/19 Correvio Pharma : to present at the H.C. Wainwright Global Life Sciences Conference PR
14/03/19 Correvio Pharma : Announces at the Market Offering PR
11/03/19 Correvio Pharma : Announces Amendment To Term Loan With CRG-Managed Funds PR
Aucun résultat pour cette recherche